Back

Can Sequencing replace traditional diagnostics in India? Traditional diagnostics are slow. Culture and antibiotic resistance tests take days or even weeks to deliver results. This can be detrimental for patients suffering from sepsis or fever of unk

In 2025, the sectors expected to see the most startup IPOs include: 1. Fintech: Leading with six companies, including Aye Finance and Pine Labs. 2. Quick Commerce: Significant growth anticipated, with major players likely to list. 3. Edtech: Co

What’s buzzing in the Indian startup ecosystem this week? QuantE Energy raised $500K seed funding to accelerate cleantech solutions a big win for India’s sustainability push. Darpan Sanghvi (Good Glamm Group) launched CoFounder Circle, a new accel

Kerala’s ₹350 Crore Tech Hub to Power 1,000 Startups The Kerala Startup Mission (KSUM) is setting up a ₹350-crore Emerging Technology Startup Hub at Technopark Phase IV (Technocity) Thiruvananthapuram. Spread over 3 acres with a 5-lakh sq ft facilit

$170 Billion. And still n$170 Billion. For a company that doesn't even have an app store yet. Anthropic is reportedly closing a $5B funding round led by Iconiq Capital, pushing its valuation to $170B—almost equal to Zoom + Adobe + Shopify combined.

*LATEST STARTUP-INVESTOR NEWS:* 1. *Peak XV leads new funding round of $15-20M* for Goodscore Parent, advancing financial inclusion in emerging markets. 2. *Angel Investor: Dubai a cheaper* weekend getaway *than Goa. “Entrepreneurs who focus on aff

Why qPCR & Phenotypic Testing Must Be Displaced – Part II If you ever want to understand the scale of a problem, look at how much it costs. Tuberculosis alone costs India, Africa, and Brazil 27 trillion INR a year in lost productivity and healthcare

Early Stage Investment Trends: A Summary of Startup Funding in India (14th-19th April) 33.4 million dollars were deployed across 13 promising Indian startups last week. The following are interesting patterns in the way investors have prioritized fun

🗞️ Medial Bulletin 🤖 AI & Automation • Takeda signs a multi-year deal worth up to $1.7B with Iambic AI to accelerate drug discovery using generative chemistry and machine learning. • AI “super-app” platforms begin emerging in the US market, combi